🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 19 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/06/2011 8,34 8,46 8,16 8,34 +0,00% 3,60% 189.583
16/06/2011 8,46 8,58 8,16 8,34 +2,21% 4,96% 196.733
15/06/2011 8,40 8,58 8,10 8,16 -4,23% 5,71% 141.133
14/06/2011 8,16 8,52 8,16 8,52 +5,19% 4,41% 166.033
13/06/2011 8,10 8,58 7,98 8,10 +0,00% 7,41% 205.283
10/06/2011 8,46 8,76 8,10 8,10 -4,93% 7,80% 313.250
09/06/2011 9,36 9,42 8,40 8,52 -8,97% 10,90% 723.733
08/06/2011 9,60 9,66 9,24 9,36 -1,27% 4,38% 140.900
07/06/2011 9,42 9,60 9,36 9,48 +1,94% 2,55% 100.850
06/06/2011 10,02 10,02 9,30 9,30 -3,12% 7,19% 146.917
03/06/2011 9,78 9,90 9,60 9,60 -2,44% 3,07% 104.517
02/06/2011 9,36 10,08 9,36 9,84 +5,81% 7,69% 233.800
01/06/2011 9,66 9,78 9,30 9,30 -3,73% 4,97% 131.017
31/05/2011 9,78 9,96 9,54 9,66 +0,63% 4,29% 146.833
27/05/2011 9,72 9,90 9,60 9,60 -1,23% 3,09% 112.517
26/05/2011 9,72 9,78 9,54 9,72 +1,89% 2,47% 87.867
25/05/2011 9,42 9,72 9,42 9,54 +1,27% 3,18% 161.450
24/05/2011 9,78 10,08 9,36 9,42 -3,68% 7,36% 187.900
23/05/2011 9,84 10,14 9,78 9,78 -1,21% 3,66% 233.333
20/05/2011 10,32 10,50 9,90 9,90 -4,62% 5,81% 172.000
19/05/2011 10,38 10,56 10,26 10,38 +0,00% 2,89% 158.483
18/05/2011 10,50 10,56 10,26 10,38 -0,57% 2,86% 125.233
17/05/2011 10,56 10,80 10,32 10,44 -1,14% 4,55% 155.267
16/05/2011 10,74 10,92 10,50 10,56 -3,30% 3,91% 164.167
13/05/2011 11,22 11,22 10,74 10,92 -2,67% 4,28% 182.200
12/05/2011 10,98 11,22 10,62 11,22 +1,08% 5,46% 216.667
11/05/2011 11,10 11,16 10,98 11,10 -0,54% 1,62% 199.733
10/05/2011 10,92 11,28 10,92 11,16 +3,33% 3,30% 261.567
09/05/2011 10,50 10,92 10,32 10,80 +3,45% 5,71% 330.217
06/05/2011 10,50 10,86 10,20 10,44 +3,57% 6,29% 216.150